Sylvan Receives Investment from Novo Holdings to Drive Further Growth April 1, 2025 April 8, 2025 Beijing, China - Novo Holdings, a leading global life science investor, and KKR, a leading global investment firm, today...
Sylvan to Expand Research Capabilities in China March 20, 2025 April 10, 2025 Huai’an, China, – Sylvan has begun construction of a new research and development facility adjacent to its spawn plant...
Sylvan Attends 17th European Conference on Fungal Genetics (ECFG) March 10, 2025 April 7, 2025 Dublin, Ireland - As a fungal biotechnology company, Sylvan couldn't miss out on the 17th ECFG Conference, that was...
New Corporate Brand Identity and Alignment with Strategy 2028 November 18, 2024 April 7, 2025 Sylvan HQ - We are proud to introduce our new Corporate Brand Identity and present the world our new...
Sylvan Europe acquires EuroMycel from Bonduelle October 14, 2024 April 7, 2025 Langeais, France – Sylvan, a leading manufacturer of fungal biotechnology solutions, today announces the acquisition of French agaricus mushroom...
French Plant Kicks Off Carbon Footprint Program C-Metric August 19, 2024 April 8, 2025 Langeais, France - This week part of the Sylvan Europe team kicked-off for the first milestone of our metric...
Sylvan Expands Capacity in China July 31, 2024 April 7, 2025 Huai’an, China – This week we successfully launched the second phase of our China spawn plant, with the completion...